Nikolaos Papadantonakis

NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018

Ruben A. Mesa, Catriona Jamieson, Ravi Bhatia et al. · Journal of the National Comprehensive Cancer Network · 2017 · 151 citations · Full text

Mixed-phenotype Acute Leukemia, Nccn Guidelines Insights, Myeloproliferative Neoplasms +16

Phytoextraction and phytoexcretion of Cd by the leaves of Tamarix smyrnensis growing on contaminated non-saline and saline soils

Eleni Manousaki, Jana Sedláková-Kaduková, Nikolaos Papadantonakis et al. · Environmental Research · 2007 · 142 citations

Tamarix Smyrnensis, Saline Soils, Botany +4

Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Jason Gotlib, Aaron T. Gerds, Prithviraj Bose et al. · Journal of the National Comprehensive Cancer Network · 2018 · 103 citations · Full text

Translational Medicine, Oncology, Autoimmune Disease +15

Control of Megakaryocyte Expansion and Bone Marrow Fibrosis by Lysyl Oxidase

Alexia Eliades, Nikolaos Papadantonakis, Ajoy Bhupatiraju et al. · Journal of Biological Chemistry · 2011 · 98 citations · Full text

Lysosomal Storage Disease, Cell Proliferation, Cell Growth +24

Clinical Profile of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Naval Daver, Pau Montesinos, Daniel J. DeAngelo et al. · Blood · 2019 · 62 citations